{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:28:07Z","timestamp":1792931287251,"version":"4.5.0"},"reference-count":275,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006013","name":"United Arab Emirates University","doi-asserted-by":"publisher","award":["G00000002"],"award-info":[{"award-number":["G00000002"]}],"id":[{"id":"10.13039\/501100006013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006013","name":"United Arab Emirates University","doi-asserted-by":"publisher","award":["12R310"],"award-info":[{"award-number":["12R310"]}],"id":[{"id":"10.13039\/501100006013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biopha.2026.119543","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T16:15:56Z","timestamp":1779725756000},"page":"119543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Signaling pathways driving multiple sclerosis: From mechanisms to natural\u2011product interventions"],"prefix":"10.1016","volume":"200","author":[{"given":"Ahmed M.","family":"El-Dessouki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba Nasr","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar S.","family":"Khalaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai A.","family":"Abd-Elmawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba R.","family":"Ghaiad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif S.","family":"Abdel Mageed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riham A.","family":"El-Shiekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadek","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9861-9693","authenticated-orcid":false,"given":"Hazim O.","family":"Khalifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119543_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jare.2019.10.012","article-title":"Long noncoding RNAs APOA1-AS, IFNG-AS1, RMRP and their related biomolecules in Egyptian patients with relapsing-remitting multiple sclerosis: relation to disease activity and patient disability","volume":"21","author":"Ghaiad","year":"2020","journal-title":"J. Adv. Res."},{"issue":"16","key":"10.1016\/j.biopha.2026.119543_bib2","doi-asserted-by":"crossref","first-page":"12631","DOI":"10.3390\/ijms241612631","article-title":"Smouldering lesion in MS: microglia, lymphocytes and pathobiochemical mechanisms","volume":"24","author":"Pukoli","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.biopha.2026.119543_bib3","doi-asserted-by":"crossref","first-page":"7354","DOI":"10.3390\/ijms25137354","article-title":"Macrophages and HLA-class II alleles in multiple sclerosis: insights in therapeutic dynamics","volume":"25","author":"Prapas","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119543_bib4","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200159","article-title":"Adaptive and innate immunity are key drivers of age at onset of multiple sclerosis","volume":"10","author":"Misicka","year":"2024","journal-title":"Neurology Genetics"},{"key":"10.1016\/j.biopha.2026.119543_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2025.110007","article-title":"Role of Vitamin D and Omega 3 Fatty Acids in Improving HDL Biogenesis among Multiple Sclerosis Patients via Orchestrating CHROME\/APOA1-AS\/ABCA1\/APOA1 Milieu","author":"Abd-Elmawla","year":"2025","journal-title":"J. Nutr. Biochem."},{"issue":"7","key":"10.1016\/j.biopha.2026.119543_bib6","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2153534","article-title":"Regulatory T cell therapy for multiple sclerosis: Breaching (blood-brain) barriers","volume":"18","author":"Verreycken","year":"2022","journal-title":"Hum. Vaccin. & Immunother."},{"issue":"21","key":"10.1016\/j.biopha.2026.119543_bib7","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.3390\/ijms232112725","article-title":"Significance of mitochondrial dysfunction in the progression of multiple sclerosis","volume":"23","author":"Blagov","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.biopha.2026.119543_bib8","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1021\/acschemneuro.3c00141","article-title":"Modulating miR-146a expression by hydrogen sulfide ameliorates motor dysfunction and axonal demyelination in cuprizone-induced multiple sclerosis","volume":"14","author":"Ghaiad","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biopha.2026.119543_bib9","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1007\/s12035-016-9891-5","article-title":"Resveratrol promotes remyelination in cuprizone model of multiple sclerosis: biochemical and histological study","volume":"54","author":"Ghaiad","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2026.119543_bib10","series-title":"Nanocarriers in neurodegenerative disorders","first-page":"29","article-title":"Neurodegenerative disorders: available therapies and their limitations","author":"Zaky","year":"2024"},{"key":"10.1016\/j.biopha.2026.119543_bib11","first-page":"1","article-title":"Sinapic Acid Mitigates Pentylenetetrazol-induced Acute Seizures By Modulating the NLRP3 Inflammasome and Regulating Calcium\/calcineurin Signaling: In Vivo and In Silico Approaches","author":"Ali","year":"2024","journal-title":"Inflammation"},{"key":"10.1016\/j.biopha.2026.119543_bib12","article-title":"Attenuation of p38 MAPK\/NF-\u03baB\/TRPV1\/CGRP is involved in the antinociceptive effect of hesperidin methyl chalcone and taxifolin in paclitaxel-induced peripheral neuropathy","author":"Abd Elaleem","year":"2024","journal-title":"BioFactors"},{"key":"10.1016\/j.biopha.2026.119543_bib13","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.5c00351","article-title":"Therapeutic Role of l-Theanine in Mitigating Cognitive Dysfunction and Neuropathology in Scopolamine-Treated Mice","author":"Elbaz","year":"2025","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119543_bib14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3390\/pharmaceutics15030749","article-title":"Plant-derived bioactive compounds in the management of neurodegenerative disorders: challenges, future directions and molecular mechanisms involved in neuroprotection","volume":"15","author":"Shoaib","year":"2023","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.biopha.2026.119543_bib15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3934\/Neuroscience.2025026","article-title":"A review of multiple sclerosis: From pathophysiology to latest therapeutic advances","volume":"12","author":"Arachchige","year":"2025","journal-title":"AIMS Neurosci."},{"key":"10.1016\/j.biopha.2026.119543_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102816","article-title":"Clinical features of late-onset multiple sclerosis: a systematic review and meta-analysis","volume":"50","author":"Naseri","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41392-025-02415-4","article-title":"Multiple sclerosis: molecular pathogenesis and therapeutic intervention","volume":"10","author":"Boutitah-Benyaich","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis\u2013a review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur. J. Neurol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119543_bib19","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41582-021-00556-y","article-title":"Apparent changes in the epidemiology and severity of multiple sclerosis","volume":"17","author":"Koch-Henriksen","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2026.119543_bib20","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Seminar multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2026.119543_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaut.2015.06.010","article-title":"The immunogenetics of multiple sclerosis: A comprehensive review","volume":"64","author":"Hollenbach","year":"2015","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.biopha.2026.119543_bib22","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200093","article-title":"Risk HLA variants affect the T-cell repertoire in multiple sclerosis","volume":"10","author":"Sorosina","year":"2023","journal-title":"Neurol. Neuroimmunol. & Neuroinflamm."},{"issue":"11","key":"10.1016\/j.biopha.2026.119543_bib23","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1136\/jnnp-2023-333296","article-title":"Pathogenesis of multiple sclerosis: genetic, environmental and random mechanisms","volume":"95","author":"Goodin","year":"2024","journal-title":"J. Neurol. Neurosurg. & Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","article-title":"Epstein\u2013Barr virus and multiple sclerosis","volume":"21","author":"Soldan","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119543_bib25","first-page":"312","article-title":"Effect of smoking on multiple sclerosis: a meta-analysis","volume":"39","author":"Poorolajal","year":"2017","journal-title":"J. Public Health"},{"issue":"10","key":"10.1016\/j.biopha.2026.119543_bib26","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","article-title":"Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria","volume":"24","author":"Montalban","year":"2025","journal-title":"Lancet Neurol."},{"issue":"3 (29)","key":"10.1016\/j.biopha.2026.119543_bib27","first-page":"329","article-title":"Diagnostic pitfalls in multiple sclerosis: how to avoid mistakes","volume":"12","author":"\u0428\u0443\u043b\u044c\u0433\u0430","year":"2025","journal-title":"\u041f\u0441\u0438\u0445\u0456\u0430\u0442\u0440\u0456\u044f \u043d\u0435\u0432\u0440\u043e\u043b\u043e\u0433\u0456\u044f \u0442\u0430 \u043c\u0435\u0434\u0438\u0447\u043d\u0430 \u043f\u0441\u0438\u0445\u043e\u043b\u043e\u0433\u0456\u044f"},{"key":"10.1016\/j.biopha.2026.119543_bib28","first-page":"10.1097","article-title":"Red flags in multiple sclerosis","author":"Bulus","year":"2025","journal-title":"Curr. Opin. Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119543_bib29","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1474-4422(15)00393-2","article-title":"MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines","volume":"15","author":"Filippi","year":"2016","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119543_bib30","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037297","article-title":"Review of multiple sclerosis: Epidemiology, etiology, pathophysiology, and treatment","volume":"103","author":"Haki","year":"2024","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.biopha.2026.119543_bib31","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/cmi.2015.44","article-title":"Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance","volume":"12","author":"Zeng","year":"2015","journal-title":"Cell. & Mol. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119543_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e29686","article-title":"Monocytes and macrophages: Origin, homing, differentiation, and functionality during inflammation","volume":"10","author":"Dash","year":"2024","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.biopha.2026.119543_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/sclerosis2030009","article-title":"Multiple Sclerosis: Immune Cells, Histopathology, and Therapeutics","volume":"2","author":"Patil","year":"2024","journal-title":"Sclerosis"},{"issue":"4","key":"10.1016\/j.biopha.2026.119543_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/medsci5040023","article-title":"Cytokine signaling in multiple sclerosis and its therapeutic applications","volume":"5","author":"Palle","year":"2017","journal-title":"Med. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib35","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-023-01620-3","article-title":"The IL-17 family in diseases: from bench to bedside","volume":"8","author":"Huangfu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib36","article-title":"Chemokines and chemokine receptors in multiple sclerosis","volume":"2014","author":"Cheng","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2026.119543_bib37","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3389\/fimmu.2020.00947","article-title":"Interleukin-17 in chronic inflammatory neurological diseases","volume":"11","author":"Milovanovic","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119543_bib38","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3389\/fimmu.2015.00492","article-title":"Stage-specific role of interferon-gamma in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"6","author":"Arellano","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119543_bib39","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fnmol.2016.00084","article-title":"NF-\u03baB pathways in the pathogenesis of multiple sclerosis and the therapeutic implications","volume":"9","author":"Leibowitz","year":"2016","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2026.119543_bib41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.expneurol.2015.11.010","article-title":"Oxidative stress in multiple sclerosis: Central and peripheral mode of action","volume":"277","author":"Ohl","year":"2016","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119543_bib42","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10571-017-0550-9","article-title":"Interactions between the canonical WNT\/beta-catenin pathway and PPAR gamma on neuroinflammation, demyelination, and remyelination in multiple sclerosis","volume":"38","author":"Vall\u00e9e","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119543_bib43","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.18632\/oncotarget.23862","article-title":"Preclinical evaluation of the PI3K\/Akt\/mTOR pathway in animal models of multiple sclerosis","volume":"9","author":"Mammana","year":"2018","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.biopha.2026.119543_bib44","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.biopha.2026.119543_bib45","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.1007\/s11033-023-08419-z","article-title":"Transforming growth factor \u03b2 (TGF-\u03b2) pathway in the immunopathogenesis of multiple sclerosis (MS); molecular approaches","volume":"50","author":"Esmaeilzadeh","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"19","key":"10.1016\/j.biopha.2026.119543_bib46","doi-asserted-by":"crossref","first-page":"14447","DOI":"10.3390\/ijms241914447","article-title":"Changes in the expression of TGF-beta regulatory pathway genes induced by vitamin D in patients with relapsing-remitting multiple sclerosis","volume":"24","author":"Lozano-Ros","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s10194-023-01616-y","article-title":"Notch signaling pathway: a new target for neuropathic pain therapy","volume":"24","author":"Zhang","year":"2023","journal-title":"J. Headache Pain."},{"issue":"19","key":"10.1016\/j.biopha.2026.119543_bib48","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1523\/JNEUROSCI.6005-11.2012","article-title":"Fibroblast growth factor receptor signaling in oligodendrocytes regulates myelin sheath thickness","volume":"32","author":"Furusho","year":"2012","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.biopha.2026.119543_bib49","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.3390\/cells10113242","article-title":"The role of fibroblast growth factor (FGF) signaling in tissue repair and regeneration","volume":"10","author":"Farooq","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib50","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.nbd.2011.08.004","article-title":"Fibroblast growth factor 1 (FGFR1) modulation regulates repair capacity of oligodendrocyte progenitor cells following chronic demyelination","volume":"45","author":"Zhou","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib51","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s40478-019-0864-6","article-title":"Polarizing receptor activation dissociates fibroblast growth factor 2 mediated inhibition of myelination from its neuroprotective potential","volume":"7","author":"Th\u00fcmmler","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"issue":"7","key":"10.1016\/j.biopha.2026.119543_bib52","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/brain\/awv102","article-title":"Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9","volume":"138","author":"Lindner","year":"2015","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.biopha.2026.119543_bib53","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00109-021-02080-4","article-title":"Multiple sclerosis is linked to MAPKERK overactivity in microglia","volume":"99","author":"Ten Bosch","year":"2021","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.biopha.2026.119543_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.bea.2022.100053","article-title":"Neural stem cell engineering for the treatment of multiple sclerosis","volume":"4","author":"Ahmed","year":"2022","journal-title":"Biomed. Eng. Adv."},{"key":"10.1016\/j.biopha.2026.119543_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2025.114769","article-title":"Molecular mechanism and the main signaling pathways in the development and progression of multiple sclerosis","author":"Naserpour","year":"2025","journal-title":"Exp. Cell Res."},{"issue":"11","key":"10.1016\/j.biopha.2026.119543_bib56","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1523\/JNEUROSCI.3316-16.2017","article-title":"Signaling by FGF receptor 2, not FGF receptor 1, regulates myelin thickness through activation of ERK1\/2\u2013MAPK, which promotes mTORC1 activity in an Akt-independent manner","volume":"37","author":"Furusho","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2026.119543_bib57","series-title":"Growth factor signaling pathways converge on the TSC complex to control mTOR","author":"Ilagan","year":"2019"},{"key":"10.1016\/j.biopha.2026.119543_bib58","series-title":"The receptor interacting protein 1 mediates a link between NF\u03baB and PI3-kinase signaling","first-page":"2671","author":"Chauncey","year":"2009"},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13024-016-0116-1","article-title":"IKK\u03b2-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1\/Th17 cell activation and compromising blood brain barrier","volume":"11","author":"Lee","year":"2016","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.biopha.2026.119543_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009380","article-title":"Myelin activates FAK\/Akt\/NF-\u03baB pathways and provokes CR3-dependent inflammatory response in murine system","volume":"5","author":"Sun","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biopha.2026.119543_bib61","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1073\/pnas.1913997117","article-title":"STAT3 signaling in myeloid cells promotes pathogenic myelin-specific T cell differentiation and autoimmune demyelination","volume":"117","author":"Lu","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2026.119543_bib62","doi-asserted-by":"crossref","first-page":"dev204589","DOI":"10.1242\/dev.204589","article-title":"Notch signaling in neurogenesis","volume":"152","author":"McLaren","year":"2025","journal-title":"Development"},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib63","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1749-8104-6-20","article-title":"Prospero and Pax2 combinatorially control neural cell fate decisions by modulating Ras-and Notch-dependent signaling","volume":"6","author":"Charlton-Perkins","year":"2011","journal-title":"Neural Dev."},{"issue":"6","key":"10.1016\/j.biopha.2026.119543_bib64","doi-asserted-by":"crossref","first-page":"eadi2671","DOI":"10.1126\/sciadv.adi2671","article-title":"Stem cell mTOR signaling directs region-specific cell fate decisions during intestinal nutrient adaptation","volume":"10","author":"Mattila","year":"2024","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib65","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12890-024-03050-5","article-title":"Sinomenine attenuates pulmonary fibrosis by downregulating TGF-\u03b21\/Smad3, PI3K\/Akt and NF-\u03baB signaling pathways","volume":"24","author":"Yao","year":"2024","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.biopha.2026.119543_bib66","doi-asserted-by":"crossref","unstructured":"Torrealba Abache, N.R., et al., TGF-beta\/PI3K\/AKT\/mTOR\/NF-kB pathway. Clinicopathological features in prostate cancer. 2020.","DOI":"10.1080\/13685538.2019.1597840"},{"key":"10.1016\/j.biopha.2026.119543_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/ana.27270","article-title":"New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond","author":"Sabatino","year":"2025","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119543_bib68","doi-asserted-by":"crossref","first-page":"507","DOI":"10.4103\/1673-5374.380901","article-title":"Multiple sclerosis drug repurposing for neuroregeneration","volume":"19","author":"G\u00f6ttle","year":"2024","journal-title":"Neural Regen. Res."},{"issue":"10","key":"10.1016\/j.biopha.2026.119543_bib69","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.3390\/biomedicines13102399","article-title":"Therapeutic Plasma Exchange in Corticosteroid-Refractory Multiple Sclerosis Relapses: Mechanisms, Efficacy, and Integration into Clinical Practice","volume":"13","author":"Marrodan","year":"2025","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.biopha.2026.119543_bib70","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s13760-024-02606-w","article-title":"Beneficial therapeutic plasma exchange response in the treatment of severe relapses in patients with multiple sclerosis","volume":"124","author":"Mesaros","year":"2024","journal-title":"Acta Neurol. Belg."},{"issue":"8","key":"10.1016\/j.biopha.2026.119543_bib71","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.2174\/1570159X22666240124114126","article-title":"Disease Modifying Strategies in Multiple Sclerosis: New Rays of Hope to Combat Disability?","volume":"22","author":"Bellanca","year":"2024","journal-title":"Curr. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119543_bib72","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00415-025-13173-2","article-title":"Personalized therapy in multiple sclerosis: an Italian Delphi consensus","volume":"272","author":"Gasperini","year":"2025","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119543_bib73","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1007\/s00415-024-12305-4","article-title":"Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption","volume":"271","author":"Singer","year":"2024","journal-title":"J. Neurol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119543_bib74","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s40263-021-00842-9","article-title":"The disease-modifying therapies of relapsing-remitting multiple sclerosis and liver injury: a narrative review","volume":"35","author":"Biolato","year":"2021","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib75","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/pharmaceutics16010120","article-title":"Personalized use of disease-modifying therapies in multiple sclerosis","volume":"16","author":"Lee","year":"2024","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.biopha.2026.119543_bib76","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41582-023-00801-6","article-title":"Inflammation in multiple sclerosis: consequences for remyelination and disease progression","volume":"19","author":"Klotz","year":"2023","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119543_bib77","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1212\/CON.0000000000001140","article-title":"Approach to symptom management in multiple sclerosis with a focus on wellness","volume":"28","author":"Spain","year":"2022","journal-title":"Continuum Lifelong Learn. Neurol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119543_bib78","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41582-025-01115-5","article-title":"Advancing multiple sclerosis management in older adults","volume":"21","author":"van der Walt","year":"2025","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib79","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/neuroglia6010006","article-title":"Clinical Management in Multiple Sclerosis","volume":"6","author":"Arredondo-Robles","year":"2025","journal-title":"Neuroglia"},{"key":"10.1016\/j.biopha.2026.119543_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106352","article-title":"Efficacy of pharmacologic treatments for fatigue in multiple sclerosis: A systematic review and meta-analysis","volume":"96","author":"Toljan","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.biopha.2026.119543_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105897","article-title":"Lifestyle intervention improves cognition and quality of life in persons with early multiple sclerosis","volume":"91","author":"Giesser","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.biopha.2026.119543_bib82","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/sclerosis3030028","article-title":"Drug Repurposing and Artificial Intelligence in Multiple Sclerosis: Emerging Strategies for Precision Therapy","volume":"3","author":"Villar-Delfino","year":"2025","journal-title":"Sclerosis"},{"issue":"7","key":"10.1016\/j.biopha.2026.119543_bib83","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3390\/cells14070533","article-title":"Repurposed Drugs to Enhance the Therapeutic Potential of Oligodendrocyte Precursor Cells Derived from Adult Rat Adipose Tissue","volume":"14","author":"Pascual-Guerra","year":"2025","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.biopha.2026.119543_bib84","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/jamaneurol.2015.4807","article-title":"Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis","volume":"73","author":"Negrotto","year":"2016","journal-title":"JAMA Neurol."},{"issue":"9936","key":"10.1016\/j.biopha.2026.119543_bib85","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0140-6736(13)62242-4","article-title":"Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial","volume":"383","author":"Chataway","year":"2014","journal-title":"Lancet"},{"issue":"10512","key":"10.1016\/j.biopha.2026.119543_bib86","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0140-6736(25)01039-6","article-title":"Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"406","author":"Chataway","year":"2025","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.biopha.2026.119543_bib87","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa1608889","article-title":"Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis","volume":"376","author":"Metz","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"10111","key":"10.1016\/j.biopha.2026.119543_bib88","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","article-title":"Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial","volume":"390","author":"Green","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.biopha.2026.119543_bib89","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/13524585231224702","article-title":"Ibudilast reduces slowly enlarging lesions in progressive multiple sclerosis","volume":"30","author":"Nakamura","year":"2024","journal-title":"Mult. Scler. J."},{"issue":"9","key":"10.1016\/j.biopha.2026.119543_bib90","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1056\/NEJMoa1803583","article-title":"Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis","volume":"379","author":"Fox","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib91","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/sclerosis3010004","article-title":"The Impact of \u03b1-Lipoic Acid Treatment on Multiple Sclerosis Disability: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"3","author":"Rodrigues","year":"2025","journal-title":"Sclerosis"},{"key":"10.1016\/j.biopha.2026.119543_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.106212","article-title":"Coenzyme Q10 supplementation in multiple sclerosis; A systematic review","volume":"93","author":"Salekzamani","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"12","key":"10.1016\/j.biopha.2026.119543_bib93","doi-asserted-by":"crossref","first-page":"14119","DOI":"10.3390\/cimb46120845","article-title":"Comparative Effects of Vitamin D Supplementation on Oxidative Stress in Relapsing\u2013Remitting Multiple Sclerosis","volume":"46","author":"Lis","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"issue":"6578","key":"10.1016\/j.biopha.2026.119543_bib94","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib95","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/13524585231215268","article-title":"A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis","volume":"30","author":"Dobson","year":"2024","journal-title":"Mult. Scler. J."},{"issue":"22","key":"10.1016\/j.biopha.2026.119543_bib96","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124714","article-title":"Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis","volume":"3","author":"Pender","year":"2018","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib97","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/ijms24010095","article-title":"The anti-inflammatory and immunomodulatory activities of natural products to control autoimmune inflammation","volume":"24","author":"Moudgil","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119543_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117177","article-title":"The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds","volume":"178","author":"Bhol","year":"2024","journal-title":"Biomed. & Pharmacother."},{"issue":"4","key":"10.1016\/j.biopha.2026.119543_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/ph14040309","article-title":"The Immunomodulatory and Anti-Inflammatory Effect of Curcumin on Immune Cell Populations, Cytokines, and In Vivo Models of Rheumatoid Arthritis","volume":"14","author":"Makuch","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2026.119543_bib100","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.intimp.2019.02.050","article-title":"M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds","volume":"70","author":"Wang","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119543_bib101","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s10787-025-01731-z","article-title":"Role of polyphenolics in the management of rheumatoid arthritis through intracellular signaling pathways: a mechanistic review","volume":"33","author":"Saleem","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"8","key":"10.1016\/j.biopha.2026.119543_bib102","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087247","article-title":"Dietary Polyphenols, Microbiome, and Multiple Sclerosis: From Molecular Anti-Inflammatory and Neuroprotective Mechanisms to Clinical Evidence","volume":"24","author":"La Rosa","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119543_bib103","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.3390\/nu11071528","article-title":"A review of various antioxidant compounds and their potential utility as complementary therapy in multiple sclerosis","volume":"11","author":"Miller","year":"2019","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.biopha.2026.119543_bib104","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s10787-022-01011-0","article-title":"Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action","volume":"30","author":"Mu\u00f1oz-Jurado","year":"2022","journal-title":"Inflammopharmacology"},{"issue":"9","key":"10.1016\/j.biopha.2026.119543_bib105","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.3390\/jcm9092916","article-title":"Melatonin improves mitochondrial dynamics and function in the kidney of z\u00fccker diabetic fatty rats","volume":"9","author":"Agil","year":"2020","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.biopha.2026.119543_bib106","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.3390\/ijms20123056","article-title":"The potential of flavonoids for the treatment of neurodegenerative diseases","volume":"20","author":"Maher","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119543_bib107","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/antiox9070609","article-title":"Antioxidant and anti-inflammatory effects of citrus flavonoid hesperetin: Special focus on neurological disorders","volume":"9","author":"Khan","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2026.119543_bib108","unstructured":"Karak, P., Biological activities of flavonoids: an overview [Internet]. IJPSR. 2019 [cited 2020 Dec 29]."},{"issue":"8","key":"10.1016\/j.biopha.2026.119543_bib109","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/jim-2016-000158","article-title":"Green tea EGCG, T-cell function, and T-cell-mediated autoimmune encephalomyelitis","volume":"64","author":"Wu","year":"2016","journal-title":"J. Invest. Med."},{"key":"10.1016\/j.biopha.2026.119543_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.555409","article-title":"Natural compounds and autophagy: allies against neurodegeneration","volume":"8","author":"Stacchiotti","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2026.119543_bib111","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-981-15-3449-2_12","article-title":"Epigenetics in multiple sclerosis","author":"Chan","year":"2020","journal-title":"Epigenetics Allergy Autoimmun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib112","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41392-023-01528-y","article-title":"Methylation across the central dogma in health and diseases: new therapeutic strategies","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2026.119543_bib113","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.2174\/1570159X20666221012122855","article-title":"Resveratrol-mediated regulation of mitochondria biogenesis-associated pathways in neurodegenerative diseases: molecular insights and potential therapeutic applications","volume":"21","author":"Shaito","year":"2023","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib114","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41598-023-50084-6","article-title":"Resveratrol attenuates high glucose-induced inflammation and improves glucose metabolism in HepG2 cells","volume":"14","author":"Tshivhase","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119543_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107749","article-title":"Natural products targeting mitochondria: emerging therapeutics for age-associated neurological disorders","volume":"221","author":"Liang","year":"2021","journal-title":"Pharmacol. & Ther."},{"key":"10.1016\/j.biopha.2026.119543_bib116","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fgene.2019.00514","article-title":"Curcumin as an Alternative Epigenetic Modulator: Mechanism of Action and Potential Effects","volume":"10","author":"Hassan","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.biopha.2026.119543_bib117","series-title":"Seminars in Cancer Biology","article-title":"Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator","author":"Li","year":"2022"},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib118","doi-asserted-by":"crossref","first-page":"12282","DOI":"10.1038\/s41598-021-89314-0","article-title":"Interactions between polyphenolic antioxidants quercetin and naringenin dictate the distinctive redox-related chemical and biological behaviour of their mixtures","volume":"11","author":"Baranowska","year":"2021","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.biopha.2026.119543_bib119","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3390\/antiox11081495","article-title":"Potential utility of natural products against oxidative stress in animal models of multiple sclerosis","volume":"11","author":"Zha","year":"2022","journal-title":"Antioxidants"},{"issue":"18","key":"10.1016\/j.biopha.2026.119543_bib120","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.3390\/nu14183723","article-title":"Effect of omega-3 fatty acids on telomeres\u2014are they the elixir of youth?","volume":"14","author":"Og\u0142uszka","year":"2022","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.biopha.2026.119543_bib121","doi-asserted-by":"crossref","first-page":"10045","DOI":"10.1007\/s12035-025-04868-8","article-title":"Epigenetic and Mitochondrial Metabolic Dysfunction in Multiple Sclerosis: A Review of Herbal Drug Approaches and Current Clinical Trials","volume":"62","author":"Ashwani","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119543_bib122","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s13311-019-00767-8","article-title":"Neuroprotective and antioxidant effect of Ginkgo biloba extract against AD and other neurological disorders","volume":"16","author":"Singh","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2026.119543_bib123","doi-asserted-by":"crossref","first-page":"12151","DOI":"10.2147\/OTT.S279002","article-title":"Berberine inhibits cell proliferation by interfering with wild-type and mutant P53 in human glioma cells","author":"Liu","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.biopha.2026.119543_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.982145","article-title":"Research progress on the pharmacological effects of berberine targeting mitochondria","volume":"13","author":"Fang","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.31083\/JIN25081","article-title":"Exploring the pathophysiology, diagnosis, and treatment options of multiple sclerosis","volume":"24","author":"Lorenzut","year":"2025","journal-title":"J. Integr. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119543_bib126","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/biof.1716","article-title":"Experimental and clinical reports on anti-inflammatory, antioxidant, and immunomodulatory effects of Curcuma longa and curcumin, an updated and comprehensive review","volume":"47","author":"Memarzia","year":"2021","journal-title":"Biofactors"},{"issue":"14","key":"10.1016\/j.biopha.2026.119543_bib127","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1055\/s-0034-1383001","article-title":"Exploring marine resources for bioactive compounds","volume":"80","author":"Kiuru","year":"2014","journal-title":"Planta Med"},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib128","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13106","article-title":"Immunomodulatory potential of flavonoids for the treatment of autoimmune diseases and tumour","volume":"95","author":"Han","year":"2022","journal-title":"Scand. J. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119543_bib129","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/jnr.24224","article-title":"Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis","volume":"96","author":"Bjelobaba","year":"2018","journal-title":"J. Neurosci. Res"},{"issue":"6","key":"10.1016\/j.biopha.2026.119543_bib130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063110","article-title":"Anti-Inflammatory Action of Resveratrol in the Central Nervous System in Relation to Glucose Concentration-An In Vitro Study on a Blood-Brain Barrier Model","volume":"25","author":"Komorowska","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119543_bib131","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/cbf.3841","article-title":"Curcumin and targeting of molecular and metabolic pathways in multiple sclerosis","volume":"41","author":"Yazdani","year":"2023","journal-title":"Cell Biochem. Funct."},{"issue":"15","key":"10.1016\/j.biopha.2026.119543_bib132","doi-asserted-by":"crossref","first-page":"8658","DOI":"10.3390\/ijms23158658","article-title":"Dual mechanism of action of curcumin in experimental models of multiple sclerosis","volume":"23","author":"ELBini-Dhouib","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119543_bib133","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/00365521.2019.1611917","article-title":"Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study","volume":"54","author":"Eaton","year":"2019","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2026.119543_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103274","article-title":"ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial","volume":"56","author":"Petracca","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"8","key":"10.1016\/j.biopha.2026.119543_bib135","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.3390\/ijms24087247","article-title":"Dietary polyphenols, microbiome, and multiple sclerosis: From molecular anti-inflammatory and neuroprotective mechanisms to clinical evidence","volume":"24","author":"La Rosa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119543_bib136","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.ajpath.2013.07.006","article-title":"Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis","volume":"183","author":"Sato","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119543_bib137","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.3390\/ijms25074047","article-title":"Intranasal resveratrol nanoparticles enhance neuroprotection in a model of multiple sclerosis","volume":"25","author":"Shamsher","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119543_bib138","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fneur.2012.00084","article-title":"Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis","volume":"3","author":"Fonseca-Kelly","year":"2012","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119543_bib139","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/WNO.0b013e3181f7f833","article-title":"Oral resveratrol reduces neuronal damage in a model of multiple sclerosis","volume":"30","author":"Shindler","year":"2010","journal-title":"J. Neuro-Ophthalmol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119543_bib140","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/1535370215618462","article-title":"Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study","volume":"241","author":"Riccio","year":"2016","journal-title":"Exp. Biol. Med."},{"issue":"7","key":"10.1016\/j.biopha.2026.119543_bib141","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1080\/1028415X.2024.2425649","article-title":"Effects of resveratrol supplementation on inflammatory markers, fatigue scale, fasting blood sugar and lipid profile in relapsing-remitting multiple sclerosis patients: a double-blind, randomized placebo-controlled trial","volume":"28","author":"Keramatzadeh","year":"2025","journal-title":"Nutr. Neurosci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119543_bib142","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1023\/B:JOCI.0000040925.55682.a5","article-title":"Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte","volume":"24","author":"Muthian","year":"2004","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119543_bib143","first-page":"110","article-title":"The immunomodulatory aspect of quercetin penta acetate on Th17 cells proliferation and gene expression in multiple sclerosis","volume":"25","author":"Ahmadi","year":"2023","journal-title":"Cell Journal (Yakhteh)"},{"key":"10.1016\/j.biopha.2026.119543_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.116980","article-title":"Quercetin regulates dendritic cell activation by targeting STAT4 in the treatment of experimental autoimmune encephalomyelitis","volume":"488","author":"Zhou","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119543_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21741","article-title":"Quercetin as a possible complementary therapy in multiple sclerosis: Anti-oxidative, anti-inflammatory and remyelination potential properties","volume":"9","author":"Javanbakht","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.biopha.2026.119543_bib146","unstructured":"Taha Fathallah, S., Neuroprotective Effects of Green Tea (Camellia sinensis) and Broccoli (Brassica oleracea) Extracts in an In Vitro Model of Multiple Sclerosis. 2023."},{"issue":"3","key":"10.1016\/j.biopha.2026.119543_bib147","doi-asserted-by":"crossref","first-page":"199","DOI":"10.5114\/fn.2017.70484","article-title":"Effects of green tea epigallocatechin-3-gallate on the proteolipid protein and oligodendrocyte transcription factor 1 messenger RNA gene expression in a mouse model of multiple sclerosis","volume":"55","author":"Semnani","year":"2017","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.biopha.2026.119543_bib148","doi-asserted-by":"crossref","unstructured":"M.R. Semnani, F. Mashayekhi, M. Azarnia, Z. Salehi, Effects of green tea epigallocatechin-3-gallate (egcg) on proteolipid protein (plp) and oligodendrocyte transcription factor 1 (olig1) expression in the cerebral cortex of cuprizone induced multiple sclerosis mice, a western blot study. 2016., and .","DOI":"10.18869\/acadpub.cjns.2.6.1"},{"issue":"3","key":"10.1016\/j.biopha.2026.119543_bib149","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000981","article-title":"Epigallocatechin gallate in relapsing-remitting multiple sclerosis: a randomized, placebo-controlled trial","volume":"8","author":"Bellmann-Strobl","year":"2021","journal-title":"Neurol. Neuroimmunol. & Neuroinflamm."},{"issue":"3","key":"10.1016\/j.biopha.2026.119543_bib150","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000964","article-title":"Epigallocatechin gallate in progressive MS: a randomized, placebo-controlled trial","volume":"8","author":"Rust","year":"2021","journal-title":"Neurol. Neuroimmunol. & Neuroinflamm."},{"issue":"3","key":"10.1016\/j.biopha.2026.119543_bib151","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3945\/ajcn.113.075309","article-title":"Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial","volume":"101","author":"M\u00e4hler","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"issue":"23","key":"10.1016\/j.biopha.2026.119543_bib152","doi-asserted-by":"crossref","first-page":"8402","DOI":"10.3390\/molecules27238402","article-title":"The multiple sclerosis modulatory potential of natural multi-targeting antioxidants","volume":"27","author":"Theodosis-Nobelos","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2026.119543_bib153","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.intimp.2019.02.035","article-title":"The therapeutic potential of ginkgolide K in experimental autoimmune encephalomyelitis via peripheral immunomodulation","volume":"70","author":"Yu","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib154","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000437429","article-title":"Enhanced neuroprotective effects of combination therapy with bone marrow-derived mesenchymal stem cells and Ginkgo biloba extract (EGb761) in a rat model of experimental autoimmune encephalomyelitis","volume":"23","author":"Hao","year":"2016","journal-title":"Neuroimmunomodulation"},{"issue":"3","key":"10.1016\/j.biopha.2026.119543_bib155","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1177\/1352458506071213","article-title":"Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial","volume":"13","author":"Lovera","year":"2007","journal-title":"Mult. Scler. J."},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib156","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.explore.2005.10.007","article-title":"The effect of Ginkgo biloba on functional measures in multiple sclerosis: a pilot randomized controlled trial","volume":"2","author":"Johnson","year":"2006","journal-title":"Explore"},{"key":"10.1016\/j.biopha.2026.119543_bib157","unstructured":"M. Noroozian, 2011, Ginkgo biloba for improvement of memory and quality of life in multiple sclerosis: An open trial. 2011."},{"key":"10.1016\/j.biopha.2026.119543_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116692","article-title":"Implication of Let7b\/AhR\/ARNT\/HMGB1\/RAGE cascade in neuroplasticity disturbances induced by glucocorticoids and the promising reversible effect of 3, 3 diindolymethane: Bidirectional crosstalk of Aryl hydrocarbon receptors","volume":"232","author":"Abd-Elmawla","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119543_bib159","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1021\/acschemneuro.5c00057","article-title":"Interplay of endoplasmic reticulum stress, inflammation, apoptosis, and oxidative stress in corticosteroid-induced anxiety and depression: exploring therapeutic potential of hydrogen sulfide and sertraline","volume":"16","author":"Azzam","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biopha.2026.119543_bib160","first-page":"1","article-title":"Integrating natural products with modern medicine in the treatment of gouty arthritis: a review","author":"Mageed","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"6","key":"10.1016\/j.biopha.2026.119543_bib161","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.70026","article-title":"Natural Products and lncRNAs in Renal Cell Carcinoma: Emerging Therapeutic Approaches","volume":"27","author":"Doghish","year":"2025","journal-title":"J. Gene Med."},{"key":"10.1016\/j.biopha.2026.119543_bib162","first-page":"1","article-title":"Alternative medicines in oncology: a focus on natural products against gastric cancer","author":"Doghish","year":"2025","journal-title":"Naunyn-Schmiede 's. Arch. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119543_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109156","article-title":"Prophylactic and therapeutic role of Betulin in mitigating obesity-related metabolic dysfunction in rats fed on high-fat diet","author":"ElHady","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2026.119543_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2025.110007","article-title":"Role of vitamin D and omega 3 fatty acids in improving HDL biogenesis among multiple sclerosis patients via orchestrating CHROME\/APOA1-AS\/ABCA1\/APOA1 milieu","volume":"145","author":"Abd-Elmawla","year":"2025","journal-title":"J. Nutr. Biochem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119543_bib165","first-page":"111","article-title":"Neurodegenerative Diseases and Phytochemicals","volume":"51","author":"Y\u0131ld\u0131r\u0131m","year":"2023","journal-title":"Beslenme ve Diyet Derg."},{"issue":"2","key":"10.1016\/j.biopha.2026.119543_bib166","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/nu18020278","article-title":"Bioactive Phytochemicals in Experimental Models of Multiple Sclerosis: Mechanisms, Efficacy, and Translational Potential","volume":"18","author":"Guo","year":"2026","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.biopha.2026.119543_bib167","first-page":"196","article-title":"MS14 down-regulates lipocalin2 expression in spinal cord tissue in an animal model of multiple sclerosis in female C57BL\/6","volume":"18","author":"Ebrahimi-Kalan","year":"2014","journal-title":"Iran. Biomed. J."},{"issue":"7","key":"10.1016\/j.biopha.2026.119543_bib168","article-title":"MS14, a marine herbal medicine, an immunosuppressive drug in experimental autoimmune encephalomyelitis","volume":"16","author":"Kalan","year":"2014","journal-title":"Iran. Red. Crescent Med. J."},{"key":"10.1016\/j.biopha.2026.119543_bib169","author":"Eghtedardoost","year":"2012","journal-title":"Eff. MS14 Hematop. blood Cells BALB\/C. mice"},{"key":"10.1016\/j.biopha.2026.119543_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104467","article-title":"Effect of MS14\u00ae on physical activity of multiple sclerosis patients: A randomized triple-blind placebo-controlled clinical trial","volume":"69","author":"Rezaeizadeh","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"10","key":"10.1016\/j.biopha.2026.119543_bib171","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1007\/s10072-020-04413-6","article-title":"Effects of THC\/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study","volume":"41","author":"Patti","year":"2020","journal-title":"Neurol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119543_bib172","doi-asserted-by":"crossref","first-page":"362","DOI":"10.37349\/en.2024.00055","article-title":"Antioxidant effects of resveratrol in granulocytes from multiple sclerosis patients","volume":"3","author":"Villar-Delfino","year":"2024","journal-title":"Explor. Neurosci."},{"key":"10.1016\/j.biopha.2026.119543_bib173","doi-asserted-by":"crossref","first-page":"4","DOI":"10.14412\/2074-2711-2024-2S-4-10","article-title":"Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy","volume":"16","author":"Kukushkina","year":"2024","journal-title":"Neurol. Neuropsychiatry Psychosom."},{"issue":"5","key":"10.1016\/j.biopha.2026.119543_bib174","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/j.1476-5381.2012.01869.x","article-title":"Natural triterpenes modulate immune-inflammatory markers of experimental autoimmune encephalomyelitis: Therapeutic implications for multiple sclerosis","volume":"166","author":"Mart\u00edn","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119543_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157448","article-title":"Therapeutic efficacy of 4-hydroxyisoleucine in experimental rat model of demyelination: Neuroprotection through IGF-1 and GLP-1 level restoration","author":"Khan","year":"2025","journal-title":"Phytomedicine"},{"issue":"13","key":"10.1016\/j.biopha.2026.119543_bib176","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.3390\/jcm12134274","article-title":"Cellular and molecular evidence of multiple sclerosis diagnosis and treatment challenges","volume":"12","author":"Khan","year":"2023","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.biopha.2026.119543_bib177","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2174\/0118715303325979241206115417","article-title":"The polygenic nature of Multiple sclerosis: genetic variants, immunological modulation, and environmental connections","volume":"25","author":"Khan","year":"2025","journal-title":"Endocr. Metab. & Immune Disord. -Drug Targets"},{"key":"10.1016\/j.biopha.2026.119543_bib178","series-title":"Phytochemicals as lead compounds for new drug discovery","first-page":"161","article-title":"Phytochemicals as therapeutic interventions in neurodegenerative diseases","author":"Kavitha","year":"2020"},{"issue":"12","key":"10.1016\/j.biopha.2026.119543_bib179","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.3390\/ijms20122876","article-title":"Phytochemicals as novel therapeutic strategies for NLRP3 inflammasome-related neurological, metabolic, and inflammatory diseases","volume":"20","author":"Pellegrini","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119543_bib180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuroscience.2024.04.004","article-title":"Immune system dysregulation in the progression of multiple sclerosis: molecular insights and therapeutic implications","volume":"548","author":"Khan","year":"2024","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2026.119543_bib181","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jconrel.2023.10.052","article-title":"Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis","volume":"364","author":"Mwema","year":"2023","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.biopha.2026.119543_bib182","first-page":"252","article-title":"Drug delivery to the central nervous system: a review","volume":"6","author":"Misra","year":"2003","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"46","key":"10.1016\/j.biopha.2026.119543_bib183","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201801362","article-title":"Overcoming the Blood-Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases","volume":"30","author":"Furtado","year":"2018","journal-title":"Adv. Mater."},{"issue":"7","key":"10.1016\/j.biopha.2026.119543_bib184","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1517\/17425247.2016.1171315","article-title":"CSF, blood-brain barrier, and brain drug delivery","volume":"13","author":"Pardridge","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"issue":"12","key":"10.1016\/j.biopha.2026.119543_bib185","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.addr.2004.07.009","article-title":"de Lange, E.C., Potential role of ABC transporters as a detoxification system at the blood-CSF barrier.","volume":"56","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119543_bib186","doi-asserted-by":"crossref","DOI":"10.1007\/s13346-026-02103-y","article-title":"Advanced modafinil-loaded transethosomes for brain targeting: development, ex-vivo permeation and radio-distribution evaluations","author":"Sayyed","year":"2026","journal-title":"Drug Deliv. Transl. Res"},{"issue":"5","key":"10.1016\/j.biopha.2026.119543_bib187","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3109\/09687688.2014.937468","article-title":"The blood-brain barrier: structure, function and therapeutic approaches to cross it","volume":"31","author":"Tajes","year":"2014","journal-title":"Mol. Membr. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119543_bib188","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2211068214561025","article-title":"TEER measurement techniques for in vitro barrier model systems","volume":"20","author":"Srinivasan","year":"2015","journal-title":"J. Lab Autom."},{"issue":"16","key":"10.1016\/j.biopha.2026.119543_bib189","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168370","article-title":"Reviewing the Significance of Blood-Brain Barrier Disruption in Multiple Sclerosis Pathology and Treatment","volume":"22","author":"Balasa","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119543_bib190","article-title":"Endoscopic-Assisted Ommaya Reservoir Placement: Technical Note","volume":"9","author":"Lane","year":"2017","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.biopha.2026.119543_bib191","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2007.08.003","article-title":"Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model","volume":"123","author":"Kim","year":"2007","journal-title":"J. Control Release"},{"issue":"23","key":"10.1016\/j.biopha.2026.119543_bib192","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1016\/j.biomaterials.2012.04.048","article-title":"Intracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model","volume":"33","author":"Masi","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2026.119543_bib193","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cobme.2017.09.002","article-title":"Nanomaterials for convection-enhanced delivery of agents to treat brain tumors","volume":"4","author":"Seo","year":"2017","journal-title":"Curr. Opin. Biomed. Eng."},{"issue":"2","key":"10.1016\/j.biopha.2026.119543_bib194","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1007049806660","article-title":"Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications","volume":"20","author":"Rapoport","year":"2000","journal-title":"Cell Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119543_bib195","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/sj.bjp.0705554","article-title":"Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries","volume":"140","author":"Erdlenbruch","year":"2003","journal-title":"Br. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib196","doi-asserted-by":"crossref","first-page":"16546","DOI":"10.1038\/s41598-020-73312-9","article-title":"Consistent opening of the blood brain barrier using focused ultrasound with constant intravenous infusion of microbubble agent","volume":"10","author":"Lapin","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119543_bib197","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.665722","article-title":"Targeted Blood Brain Barrier Opening With Focused Ultrasound Induces Focal Macrophage\/Microglial Activation in Experimental Autoimmune Encephalomyelitis","volume":"15","author":"Schregel","year":"2021","journal-title":"Front Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib198","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1208\/s12248-008-9009-8","article-title":"Prodrug approaches for CNS delivery","volume":"10","author":"Rautio","year":"2008","journal-title":"AAPS J."},{"issue":"7","key":"10.1016\/j.biopha.2026.119543_bib199","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s11095-022-03241-x","article-title":"Targeting Transporters for Drug Delivery to the Brain: Can We Do Better?","volume":"39","author":"Puris","year":"2022","journal-title":"Pharm. Res"},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib200","doi-asserted-by":"crossref","first-page":"13334","DOI":"10.1038\/s41598-020-70290-w","article-title":"Plasmid DNA gene therapy of the Niemann-Pick C1 mouse with transferrin receptor-targeted Trojan horse liposomes","volume":"10","author":"Jiang","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119543_bib201","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2020.602236","article-title":"Brain Delivery of Nanomedicines: Trojan Horse Liposomes for Plasmid DNA Gene Therapy of the Brain","volume":"2","author":"Pardridge","year":"2020","journal-title":"Front Med Technol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119543_bib202","first-page":"531","article-title":"Repurposing linagliptin-loaded novasomes as a neuroprotectant for Alzheimer's disease: in-vitro characterisation, statistical optimisation and ex-vivo permeation study","volume":"42","author":"Farag","year":"2025","journal-title":"J. Micro"},{"key":"10.1016\/j.biopha.2026.119543_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107061","article-title":"Intranasal propranolol hydrochloride-loaded PLGA-lipid hybrid nanoparticles for brain targeting: Optimization and biodistribution study by radiobiological evaluation","volume":"208","author":"Albash","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2026.119543_bib204","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejpb.2018.05.009","article-title":"Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics","volume":"128","author":"Bourganis","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2026.119543_bib205","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jneumeth.2018.03.006","article-title":"Methodology and effects of repeated intranasal delivery of DNSP-11 in awake Rhesus macaques","volume":"303","author":"Stenslik","year":"2018","journal-title":"J. Neurosci. Methods"},{"issue":"3","key":"10.1016\/j.biopha.2026.119543_bib206","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-026-03366-x","article-title":"Engineered Novel Brijaluronic Terpesomes for Brain-Targeted Quercetin Delivery: Optimization, Ex Vivo and Radiokinetics","volume":"27","author":"Ahmed","year":"2026","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"10.1016\/j.biopha.2026.119543_bib207","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1124\/jpet.119.258152","article-title":"Nose-to-Brain Delivery","volume":"370","author":"Wang","year":"2019","journal-title":"J. Pharm. Exp. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2026.119543_bib208","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10030116","article-title":"Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa","volume":"10","author":"Ganger","year":"2018","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib209","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119543_bib210","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1089\/jamp.2011.0924","article-title":"Nasal deposition and clearance in man: comparison of a bidirectional powder device and a traditional liquid spray pump","volume":"25","author":"Djupesland","year":"2012","journal-title":"J. Aerosol Med Pulm. Drug Deliv."},{"key":"10.1016\/j.biopha.2026.119543_bib211","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jddst.2016.05.003","article-title":"Formulation and device design to increase nose to brain drug delivery","volume":"35","author":"Warnken","year":"2016","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.biopha.2026.119543_bib212","article-title":"From bench to biology: Unraveling the efficiency of novel brijosomes for trans-tympanic drug delivery","volume":"114","author":"Ahmed","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119543_bib213","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1208\/s12249-025-03233-1","article-title":"The Road to Precision Nanomedicine: An Insight on Drug Repurposing and Advances in Nanoformulations for Treatment of Cancer","volume":"26","author":"Elmahboub","year":"2025","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.biopha.2026.119543_bib214","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/14737175.2021.1886926","article-title":"Gene and cell therapy and nanomedicine for the treatment of multiple sclerosis: bibliometric analysis and systematic review of clinical outcomes","volume":"21","author":"Caballero-Villarraso","year":"2021","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.biopha.2026.119543_bib215","article-title":"Review on theranostic and neuroprotective applications of nanotechnology in multiple sclerosis","volume":"81","author":"Sharma","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119543_bib216","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10060338","article-title":"Promising Nanotechnology Approaches in Treatment of Autoimmune Diseases of Central Nervous System","volume":"10","author":"Chountoulesi","year":"2020","journal-title":"Brain Sci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119543_bib217","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.tibtech.2018.02.008","article-title":"Antigen-Specific Tolerization and Targeted Delivery as Therapeutic Strategies for Autoimmune Diseases","volume":"36","author":"Shakya","year":"2018","journal-title":"Trends Biotechnol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119543_bib218","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1517\/17425247.2013.762354","article-title":"Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB","volume":"10","author":"Nagpal","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"issue":"10","key":"10.1016\/j.biopha.2026.119543_bib219","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/s41563-024-02114-5","article-title":"Blood-brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system","volume":"24","author":"Wang","year":"2025","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biopha.2026.119543_bib220","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1746918","article-title":"Innovative Dual-Functional Hybrid Cationic PEGylated Proniosomes as a Smart Nano-platform for Boosted Vaginal Delivery: Multi-Level In-Vitro, Ex-Vivo, Microbiological, and In-Vivo Studies","author":"Ahmed","year":"2026","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2026.119543_bib221","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-026-03342-5","article-title":"Harnessing Novel Tetra-Synergistic Bilosomes for Effective Otomycosis Management: Integrated In-Vitro, Microbiological and In-Vivo Studies","author":"Fahmy","year":"2026","journal-title":"AAPS PharmSciTech"},{"issue":"10","key":"10.1016\/j.biopha.2026.119543_bib222","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2174\/0118715273283338240104112106","article-title":"Application of Nanocomposites and Nanoparticles in Treating Neurodegenerative Disorders","volume":"23","author":"Fatima","year":"2024","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"1-2","key":"10.1016\/j.biopha.2026.119543_bib223","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2006.07.006","article-title":"Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness","volume":"180","author":"Link","year":"2006","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119543_bib224","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1002\/jbm.a.34586","article-title":"Micro-nanopatterning as tool to study the role of physicochemical properties on cell-surface interactions","volume":"101","author":"Singh","year":"2013","journal-title":"J. Biomed. Mater. Res A"},{"issue":"2","key":"10.1016\/j.biopha.2026.119543_bib225","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jconrel.2012.03.026","article-title":"Therapeutics, imaging and toxicity of nanomaterials in the central nervous system","volume":"161","author":"Nunes","year":"2012","journal-title":"J. Control Release"},{"issue":"4","key":"10.1016\/j.biopha.2026.119543_bib226","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1109\/MPUL.2017.2701488","article-title":"Sniffing for Cancer: Nano Noses Hold Promise for Detecting Lung Cancer and Other Diseases","volume":"8","author":"Fischer","year":"2017","journal-title":"IEEE Pulse"},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib227","doi-asserted-by":"crossref","first-page":"10046","DOI":"10.1038\/s41598-019-46566-1","article-title":"MRI coupled with clinically-applicable iron oxide nanoparticles reveals choroid plexus involvement in a murine model of neuroinflammation","volume":"9","author":"Hubert","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib228","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.kint.2016.12.037","article-title":"Current and potential imaging applications of ferumoxytol for magnetic resonance imaging","volume":"92","author":"Toth","year":"2017","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.biopha.2026.119543_bib229","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1021\/acsnano.5b07573","article-title":"Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and Imaging","volume":"10","author":"Han","year":"2016","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.biopha.2026.119543_bib230","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci7070078","article-title":"Multiple Sclerosis: Immunopathology and Treatment Update","volume":"7","author":"Dargahi","year":"2017","journal-title":"Brain Sci."},{"key":"10.1016\/j.biopha.2026.119543_bib231","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jconrel.2020.11.019","article-title":"Intranasal delivery of interferon-beta-loaded nanoparticles induces control of neuroinflammation in a preclinical model of multiple sclerosis: A promising simple, effective, non-invasive, and low-cost therapy","volume":"331","author":"Gonzalez","year":"2021","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2026.119543_bib232","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.colsurfb.2017.10.062","article-title":"Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation","volume":"161","author":"Graverini","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2026.119543_bib233","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jddst.2016.06.012","article-title":"Brain delivery of baclofen as a hydrophilic drug by nanolipid carriers: Characteristics and pharmacokinetics evaluation","volume":"37","author":"Ghasemian","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119543_bib234","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S1474-4422(17)30302-2","article-title":"Unravelling neurodegeneration in multiple sclerosis","volume":"16","author":"Bermel","year":"2017","journal-title":"Lancet Neurol."},{"issue":"1-2","key":"10.1016\/j.biopha.2026.119543_bib235","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jneuroim.2006.03.027","article-title":"Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases","volume":"176","author":"Dhib-Jalbut","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.biopha.2026.119543_bib236","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.2147\/IJN.S515951","article-title":"Yttrium Oxide Nanoparticles Affect Both Cognitive and Memory Function by Disrupting Copper Output in Neuronal Cells in a Rat Model","volume":"20","author":"Zheng","year":"2025","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119543_bib237","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2024.137895","article-title":"Yttrium oxide nanoparticles alleviate cognitive deficits, neuroinflammation, and mitochondrial biogenesis impairment induced by streptozotocin","volume":"837","author":"Baghaee","year":"2024","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2026.119543_bib238","first-page":"1159","article-title":"Cerium oxide nanoparticles promote neurogenesis and abrogate hypoxia-induced memory impairment through AMPK-PKC-CBP signaling cascade","volume":"11","author":"Arya","year":"2016","journal-title":"Int J. Nanomed."},{"issue":"13","key":"10.1016\/j.biopha.2026.119543_bib239","doi-asserted-by":"crossref","first-page":"11482","DOI":"10.1021\/acsami.7b01077","article-title":"Water-Soluble Fullerene Derivatives as Brain Medicine: Surface Chemistry Determines If They Are Neuroprotective and Antitumor","volume":"9","author":"Hsieh","year":"2017","journal-title":"ACS Appl. Mater. & Interfaces"},{"issue":"46","key":"10.1016\/j.biopha.2026.119543_bib240","doi-asserted-by":"crossref","first-page":"12202","DOI":"10.1021\/acs.langmuir.6b03022","article-title":"Redox-Sensitive Cerium Oxide Nanoparticles Protect Human Keratinocytes from Oxidative Stress Induced by Glutathione Depletion","volume":"32","author":"Singh","year":"2016","journal-title":"Langmuir"},{"key":"10.1016\/j.biopha.2026.119543_bib241","first-page":"378","article-title":"Polyhydroxylated fullerene nanoparticles attenuate brain infarction and oxidative stress in rat model of ischemic stroke","volume":"15","author":"Vani","year":"2016","journal-title":"Excli J."},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib242","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neulet.2011.06.023","article-title":"Neurite outgrowth of dorsal root ganglia neurons is enhanced on aligned nanofibrous biopolymer scaffold with carbon nanotube coating","volume":"501","author":"Jin","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"9","key":"10.1016\/j.biopha.2026.119543_bib243","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2217\/nnm.10.89","article-title":"Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration","volume":"5","author":"Dai","year":"2010","journal-title":"Nanomed. (Lond. )"},{"issue":"2","key":"10.1016\/j.biopha.2026.119543_bib244","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pharma.2022.08.010","article-title":"Nose-to-brain delivery of paliperidone palmitate poloxamer-guar gum nanogel: Formulation, optimization and pharmacological studies in rats","volume":"81","author":"Gadhave","year":"2023","journal-title":"Ann. Pharm. Fr."},{"issue":"2","key":"10.1016\/j.biopha.2026.119543_bib245","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1166\/jbn.2015.1907","article-title":"Implant-Assisted Intrathecal Magnetic Drug Targeting to Aid in Therapeutic Nanoparticle Localization for Potential Treatment of Central Nervous System Disorders","volume":"11","author":"Lueshen","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119543_bib246","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/03639045.2019.1576724","article-title":"Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies","volume":"45","author":"Gadhave","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.biopha.2026.119543_bib247","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jconrel.2021.05.027","article-title":"New strategy for MS treatment with autoantigen-modified liposomes and their therapeutic effect","volume":"335","author":"Shimizu","year":"2021","journal-title":"J. Control Release"},{"issue":"6","key":"10.1016\/j.biopha.2026.119543_bib248","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11357-019-00102-1","article-title":"Fusogenic liposomes effectively deliver resveratrol to the cerebral microcirculation and improve endothelium-dependent neurovascular coupling responses in aged mice","volume":"41","author":"Wiedenhoeft","year":"2019","journal-title":"Geroscience"},{"key":"10.1016\/j.biopha.2026.119543_bib249","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121050","article-title":"Nose-to-brain delivery of amisulpride-loaded lipid-based poloxamer-gellan gum nanoemulgel: In vitro and in vivo pharmacological studies","volume":"607","author":"Gadhave","year":"2021","journal-title":"Int J. Pharm."},{"issue":"16","key":"10.1016\/j.biopha.2026.119543_bib250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168884","article-title":"PLGA\/PLA-Based Long-Acting Injectable Depot Microspheres in Clinical Use: Production and Characterization Overview for Protein\/Peptide Delivery","volume":"22","author":"Butreddy","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2026.119543_bib251","doi-asserted-by":"crossref","DOI":"10.3390\/polym12123063","article-title":"Poly(d,l-lactide-co-glycolide) (PLGA) Nanoparticles Loaded with Proteolipid Protein (PLP)-Exploring a New Administration Route","volume":"12","author":"Lima","year":"2020","journal-title":"Polymers"},{"issue":"11","key":"10.1016\/j.biopha.2026.119543_bib252","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1021\/acs.molpharmaceut.2c00277","article-title":"Development of PLGA Nanoparticles with a Glycosylated Myelin Oligodendrocyte Glycoprotein Epitope (MOG(35-55)) against Experimental Autoimmune Encephalomyelitis (EAE)","volume":"19","author":"Triantafyllakou","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2026.119543_bib253","article-title":"Multiple Sclerosis: LIFNano-CD4 for Trojan Horse Delivery of the Neuro-Protective Biologic \"LIF\" Into the Brain: Preclinical Proof of Concept","volume":"3","author":"de la Flor","year":"2021","journal-title":"Front Med Technol."},{"issue":"27","key":"10.1016\/j.biopha.2026.119543_bib254","doi-asserted-by":"crossref","first-page":"15893","DOI":"10.1039\/C9RA09928J","article-title":"Sustained in vitro interferon-beta release and in vivo toxicity of PLGA and PEG-PLGA nanoparticles","volume":"10","author":"Fodor-Kardos","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.biopha.2026.119543_bib255","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.112091","article-title":"Switch off inflammation in spleen cells with CD40-targeted PLGA nanoparticles containing dimethyl fumarate","volume":"208","author":"Khosravi","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2026.119543_bib256","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.732954","article-title":"Nano-in-Micro-Particles Consisting of PLGA Nanoparticles Embedded in Chitosan Microparticles via Spray-Drying Enhances Their Uptake in the Olfactory Mucosa","volume":"12","author":"Spindler","year":"2021","journal-title":"Front Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2026.119543_bib257","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102252","article-title":"Exosomes as CNS Drug Delivery Tools and Their Applications","volume":"14","author":"Sun","year":"2022","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.biopha.2026.119543_bib258","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/1352458517696597","article-title":"Multiple sclerosis: Serum-derived exosomes express myelin proteins","volume":"24","author":"Galazka","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.biopha.2026.119543_bib259","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jconrel.2022.12.026","article-title":"Resveratrol-loaded macrophage exosomes alleviate multiple sclerosis through targeting microglia","volume":"353","author":"Zheng","year":"2023","journal-title":"J. Control Release"},{"issue":"3","key":"10.1016\/j.biopha.2026.119543_bib260","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1021\/acsbiomaterials.0c01592","article-title":"Neuroinflammatory Regulation of Gold Nanoparticles Conjugated to Ethylene Dicysteine Diethyl Ester in Experimental Autoimmune Encephalomyelitis","volume":"7","author":"Souza","year":"2021","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.biopha.2026.119543_bib261","article-title":"Peptide mediated targeted delivery of gold nanoparticles into the demyelination site ameliorates myelin impairment and gliosis","volume":"47","author":"Farhangi","year":"2023","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2026.119543_bib262","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102893","article-title":"Comparative effectiveness of preventive treatment with dimethyl fumarate-loaded solid lipid nanoparticles and oral dimethyl fumarate in a mouse model of multiple sclerosis","volume":"132","author":"Bevilacqua Rolfsen Ferreira da Silva","year":"2022","journal-title":"J. Autoimmun."},{"issue":"43","key":"10.1016\/j.biopha.2026.119543_bib263","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1016\/j.vaccine.2014.08.016","article-title":"Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis","volume":"32","author":"Cappellano","year":"2014","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.biopha.2026.119543_bib264","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202590","article-title":"Therapeutic potential of extracellular vesicles derived from human mesenchymal stem cells in a model of progressive multiple sclerosis","volume":"13","author":"Laso-Garcia","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib265","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/s41598-020-58709-w","article-title":"Nanocatalytic activity of clean-surfaced, faceted nanocrystalline gold enhances remyelination in animal models of multiple sclerosis","volume":"10","author":"Robinson","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119543_bib266","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148674","article-title":"Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: Multiple sclerosis","volume":"1822","author":"Gadhave","year":"2024","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.biopha.2026.119543_bib267","article-title":"EGF-Coupled Gold Nanoparticles Increase the Expression of CNPase and the Myelin-Associated Proteins MAG, MOG, and MBP in the Septal Nucleus Demyelinated by Cuprizone","volume":"12","author":"Lira-Diaz","year":"2022","journal-title":"Life (Basel)"},{"issue":"7","key":"10.1016\/j.biopha.2026.119543_bib268","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25074047","article-title":"Intranasal Resveratrol Nanoparticles Enhance Neuroprotection in a Model of Multiple Sclerosis","volume":"25","author":"Shamsher","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119543_bib269","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10534-024-00648-4","article-title":"Berberine-loaded iron oxide nanoparticles alleviate cuprizone-induced astrocytic reactivity in a rat model of multiple sclerosis","volume":"38","author":"Ibrahim Fouad","year":"2025","journal-title":"Biometals"},{"key":"10.1016\/j.biopha.2026.119543_bib270","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuropharm.2015.07.013","article-title":"Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair","volume":"99","author":"Mohajeri","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2026.119543_bib271","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/IJN.S214349","article-title":"Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis","volume":"15","author":"Hsiao","year":"2020","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119543_bib272","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.166145","article-title":"Glycolysis-regulating polyphenol nanoparticles restore immune homeostasis and tolerance in autoimmune multiple sclerosis","volume":"520","author":"Phan","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"4","key":"10.1016\/j.biopha.2026.119543_bib273","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.7150\/ijbs.90982","article-title":"Polyphenols targeting NF-\u03baB pathway in neurological disorders: what we know so far?","volume":"20","author":"Al Mamun","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"17","key":"10.1016\/j.biopha.2026.119543_bib274","doi-asserted-by":"crossref","first-page":"9588","DOI":"10.3390\/ijms25179588","article-title":"Glial cells as key regulators in neuroinflammatory mechanisms associated with multiple sclerosis","volume":"25","author":"Theophanous","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2026.119543_bib275","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/cns.14176","article-title":"FGF\/FGFR system in the central nervous system demyelinating disease: Recent progress and implications for multiple sclerosis","volume":"29","author":"Zhang","year":"2023","journal-title":"CNS Neurosci. & Ther."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:47:54Z","timestamp":1787438874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226005792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":275,"alternative-id":["S0753332226005792"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119543","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Signaling pathways driving multiple sclerosis: From mechanisms to natural\u2011product interventions","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119543","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119543"}}